CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Soterix 1x1 tDCS LTE Stimulator Device Model 1401device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05071586
NCT05071586N/ACompleted
CompareCT.gov

Remotely Monitored Transcranial Direct Current Stimulation in Children With Cerebral Palsy

University of Wisconsin, Madison·interventional·Posted Oct 8, 2021·Updated May 7, 2024

In Brief

A clinical study evaluating Soterix 1x1 tDCS LTE Stimulator Device Model 1401 for Cerebral Palsy (CP). Completed, enrolled 10 participants across 1 site.

Detailed Summary

This study will explore using remotely monitored 'active' non-invasive brain stimulation in children with cerebral palsy. Participants will receive active non-invasive brain stimulation with synchronous safety monitoring and guided instruction with laboratory staff after appropriate training. Participants will be between 8-21 years old and have a diagnosis of hemiparetic cerebral palsy with a history of a perinatal stroke or brain bleed, and can expect to be in the study for 5 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy (CP)
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 8, 2021
Enrollment StartDec 21, 2022
Primary CompletionJun 6, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.7 years ago

Interventions

Soterix 1x1 tDCS LTE Stimulator Device Model 1401device

Participants will receive 20 minutes of 1.5 mA (Milliampere) transcranial direct current stimulation (tDCS) via Soterix 1x1 tDCS LTE Stimulator Device Model 1401 with a bilateral M1 montage.